The lupus anticoagulant-hypoprothrombinemia syndrome (LAHS)—the association of
acquired factor II deficiency and lupus anticoagulant—is a rare disease drastically different …

Lupus anticoagulant-hypoprothrombinemia syndrome (LA-HPS) is a rare acquired disorder
caused by prothrombin antibodies. The disease is most common in the pediatric age group …

We describe two patients whose initial presentation of systemic lupus erythematosus (SLE)
was accompanied by haemorrhagic episodes and significant coagulopathy. Further …

Patients with lupus anticoagulant (LA), a thrombotic risk factor, along with decreased
prothrombin (FII) activity are classified as lupus anticoagulant-hypoprothrombinemia …

A 17-year-old girl was admitted to our department with a hemorrhagic syndrome due to a
serious coagulopathy; prothrombin time (PT) INR was 2.46 and the activated partial …

Introduction Lupus anticoagulant associated with acquired prothrombin deficiency also
known as 'lupus anticoagulant hypoprothrombinemia syndrome'(LAHS) is an entity that is …

We report a severe hemorrhagic disorder in two pediatric patients with lupus anticoagulant
(LA) associated to acquired factor II (prothrombin) deficiency. In both patients, hemorrhagic …

Objective Children with lupus anticoagulant hypoprothrombinemia syndrome (LAHPS) are
characterized by prolonged activated partial thromboplastin time (APTT) and prothrombin …

We report two children with systemic lupus erythematosus (SLE) having severe bleeding
manifestations and lupus anticoagulant hypoprothrombinemia syndrome (LAHPS) along …

Introduction Lupus anticoagulant hypoprothrombinemia syndrome (LAHPS) is a rare
phenomenon that leads to concomitant thrombosis and hemorrhage in children with SLE …